Accurate and definitive results that enhance patient care

The BD SurePath™ Liquid-based Pap Test is your trusted partner from sample collection to result reporting.

The BD SurePath™ Liquid-based Pap Test is an FDA and CE-marked cytology method with higher cervical disease detection and lower unsatisfactory rate compared to conventional cytology and other liquid-based cytology (LBC) devices.¹

A simple and efficient cell collection that ensures sample quality
 

• The head of the collection device is deposited directly into the BD SurePath™ Collection Vial so 100% of the collected cells are sent to the laboratory for analysis – unlike the rinsing method which can result in up to 37% of cells being discarded.^2,3
• The cells are preserved in an ethanol solution for optimal slide preparation in the lab.⁴
• The same sample can be used for cytology testing, immunocytochemistry, and HPV testing.^4-6

See how BD SurePath™ can help you to collect cervical samples of high quality for cytology and molecular testing.

A unique and standardised sample processing that offers homogenous slides
 

• BD SurePath™ Liquid-based Pap Test uses a proprietary cell enrichment process to eliminate blood, inflammatory cells, mucus and other debris. Only the most diagnostically relevant material is presented on the slide, offering a clear background.^7,8

• Automated slide preparation with on-board staining results in a 13 mm deposition area and uniform distribution of the cells in a thin layer.⁹

Check out the quality of slides obtained with BD SurePath™ Liquid-based Pap Test

Accurate and definitive results that enhance patient care

The BD SurePath™ Liquid-based Pap Test is your trusted partner from sample collection to result reporting.

ASC-US, atypical squamous cells of undetermined significance; FDA, Food and Drug Administration; HPV, human papillomavirus; HSIL, high-grade squamous intraepithelial lesions; LBC, liquid-based cytology; LSIL, low-grade squamous intraepithelial lesions; Pap, Papanicolaou; SIL, squamous intraepithelial lesions.

1. Fremont-Smith M et al. Cancer. 2004;102(5):269–79.
2. Nance KV. Diagn Cytopathol. 2007;35(3):148–53.
3. Bigras G et al. J Low Genit Tract Dis. 2003;7(3):168–74.
4. BD SurePath™ Collection Vial Package Insert (500017013).
5. CINtec® PLUS Cytology Kit Package Insert.
6. BD Onclarity™ HPV Assay Package Insert (8089899).
7. Sweeney BJ et al. Cancer Cytopathol. 2006; 108(1): 27–31
8. Kenyon S et al. Cancer Cytopathol. 2010;118(5):244–9.
9. BD Totalys™ SlidePrep Instrument User’s Manual (500005570).
10. Ransdell JS et al. Cancer Cytopathol. 1997;81(3):139–43.
11. Nygård JF et al. J Med Screen. 2004;11(2):70–6.
12. Rozemeijer K et al. BMJ. 2017;356:j504.